Skip to content
Prism Medico & Pharmacy logo

Prism Medico & Pharmacy

512217 BSE
₹34.16

Close ·

P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 4 Nov 2026 ₹34.16 +14.32 +72.2% 1Y
Start ₹19.84

Key Fundamentals

MicrocapFinanceFinancial Services

Price-based figures at the close · EPS basis: Standalone · TTM

Debt to Equity
0.00
EPS (TTM)
−₹0.59
Book Value
₹16.89
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
2.02
ROE
2.10%
Dividend Yield
0.00%
52W High
₹37.00
52W Low
₹15.51
ROCE
Not meaningful for a lender: the ratio describes an industrial company’s balance sheet
EBITDA
Not meaningful for a lender: the ratio describes an industrial company’s balance sheet

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

45 Average

Data confidence 88/100

Category scores

Quality
50
Average
Returns, margins, earnings quality 22% weight
Valuation
40
Weak
Cheap vs sector & own history 24% weight
Growth
16
Poor
Sales & profit trajectory 9% weight
Financial Health
18
Poor
Solvency, leverage, coverage 9% weight
Momentum
83
Strong
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

4
  • Company has low interest coverage ratio.
  • Promoter holding is low: 30.0%
  • Company has a low return on equity of 0.55% over last 3 years.
  • Company has high debtors of 595 days.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish2710
OscillatorsBullish072
Moving AveragesStrong Bullish208

Key readings

RSI (14)
58.22
Neutral
MACD (12,26,9)
1.41
Bullish
SMA (50)
30.72
Bullish
SMA (200)
27.36
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+38.92%
5Y−32.15%
3Y+23.80%
1Y+282.54%
TTM−60.65%

Net profit

Net profit growth by window
10YTurned to profit
5YTurned to profit
3YTurned to profit
1YTurned to profit
TTMTurned to loss

Operating cash flow

Not meaningful

A bank's or NBFC's operating cash flow moves with deposits and loans, so its growth says little about the business.

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹0.09 Cr
Mar 2018₹20.96 Cr
Mar 2019₹36.31 Cr
Mar 2020₹26.89 Cr
Mar 2021₹16.76 Cr
Mar 2022₹8.44 Cr
Mar 2023₹1.27 Cr
Mar 2024₹2.93 Cr
Mar 2025₹0.63 Cr
Mar 2026₹2.41 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017−₹0.23 Cr
Mar 2018−₹0.02 Cr
Mar 2019₹0.37 Cr
Mar 2020−₹0.05 Cr
Mar 2021−₹0.13 Cr
Mar 2022−₹0.37 Cr
Mar 2023−₹0.08 Cr
Mar 2024−₹0.02 Cr
Mar 2025−₹0.05 Cr
Mar 2026₹0.32 Cr

Quarterly Results

₹ Cr
512217 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
0
0.03
2.75
0.15
0.06
0.29
0.21
0.07
1.59
0.5
0.07
0.28
0
Expenses
0.11
0.09
2.56
0.32
0.15
0.28
0.22
0.06
0.94
0.6
0.09
0.4
0.15
Financing Profit
−0.11
−0.06
0.19
−0.17
−0.09
0.01
−0.01
0.01
0.65
−0.1
−0.02
−0.12
−0.15
Fin. Margin %
—
−200%
6.91%
−113.33%
−150%
3.45%
−4.76%
14.29%
40.88%
−20%
−28.57%
−42.86%
—
Other Income
0.02
0.01
0
0.1
0
0
0
0.01
0
0.02
0.01
0
0.09
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
−0.09
−0.05
0.19
−0.07
−0.09
0.01
−0.01
0.02
0.65
−0.08
−0.01
−0.12
−0.06
Tax %
0%
0%
0%
−14.29%
0%
0%
0%
−100%
−1.54%
0%
0%
100%
0%
Net Profit
−0.09
−0.05
0.19
−0.07
−0.09
0.01
−0.01
0.04
0.66
−0.08
−0.01
−0.24
−0.06
EPS (₹)
−0.15
−0.08
0.31
−0.12
−0.15
0.02
−0.02
0.07
1.09
−0.13
−0.02
−0.4
−0.04

Profit & Loss

₹ Cr
512217 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
0
0.09
0.09
20.96
36.31
26.89
16.76
8.44
1.27
2.93
0.63
2.41
0.85
Expenses
0.06
0.15
0.37
20.86
35.98
26.94
16.92
8.93
1.37
3.06
0.71
2.01
1.24
Financing Profit
−0.06
−0.06
−0.28
0.1
0.33
−0.05
−0.16
−0.49
−0.1
−0.14
−0.08
0.4
−0.39
Fin. Margin %
—
−66.67%
−311.11%
0.48%
0.91%
−0.19%
−0.95%
−5.81%
−7.87%
−4.78%
−12.7%
16.6%
−45.88%
Other Income
0.06
0.06
0.07
−0.01
−0.01
0
0
0
0
0.12
0.02
0.03
0.12
Interest
0
0
0
0
0
0
0
0
0
0.01
0
0
0
Depreciation
0.01
0.01
0.02
0.04
0.03
0.02
0.01
0.01
0.01
0.01
0
0
0
PBT
−0.01
−0.01
−0.23
0.05
0.29
−0.07
−0.17
−0.5
−0.11
−0.03
−0.06
0.43
−0.27
Tax %
0%
0%
0%
140%
−24.14%
−28.57%
−29.41%
−26%
−27.27%
−33.33%
−33.33%
25.58%
—
Net Profit
−0.01
−0.01
−0.23
−0.02
0.37
−0.05
−0.13
−0.37
−0.08
−0.02
−0.05
0.32
−0.39
EPS (₹)
−0.05
−0.05
−0.38
−0.03
0.61
−0.08
−0.21
−0.61
−0.13
−0.03
−0.08
0.53
−0.59
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
512217 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1.99
1.99
6.06
6.06
6.06
6.06
6.06
6.06
6.06
6.06
6.06
6.06
Reserves
−0.36
−0.36
6.74
6.72
7.09
6.99
6.86
6.49
9.1
9.08
9.03
9.35
Borrowing
0.02
0.07
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0.04
0.16
0.25
0.16
3.82
8.54
8.63
0.02
0.23
0.1
0.47
0.2
Total Liabilities
1.69
1.86
13.05
12.94
16.97
21.59
21.55
12.57
15.39
15.24
15.56
15.61
Fixed Assets
0.01
0
0.16
0.11
0.09
0.07
0.06
0.05
0.03
0.03
0.03
0.03
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
10
11.25
10
1.94
1.94
0
0
0
0
0
Other Assets
1.68
1.86
2.89
1.58
6.88
19.58
19.55
12.52
15.36
15.21
15.53
15.58
Total Assets
1.69
1.86
13.05
12.94
16.97
21.59
21.55
12.57
15.39
15.24
15.56
15.61

Cash Flow

₹ Cr
512217 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.01
0.05
−0.82
−0.06
−1.23
−4.36
−0.05
−2.38
2.95
−0.01
−0.02
0
Investing
0
0.46
0.3
−1.25
1.25
4.36
0.02
2.35
−2.91
0
0
0
Financing
0.02
0.05
1.33
−0.05
0.06
0
0
0
0
−0.01
0
0
Net Cash Flow
0.02
0.56
0.81
−1.36
0.08
−0.01
−0.03
−0.03
0.04
−0.01
−0.02
0
Free Cash Flow
0.01
0.05
−0.99
−0.06
−1.23
−4.36
−0.05
−2.38
2.95
−0.01
−0.02
0

Ratios

512217 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROE %
−0.61%
−0.61%
−3.19%
−0.16%
4.24%
−0.38%
−1%
−2.91%
−0.58%
−0.13%
−0.33%
2.1%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Prism Medico & Pharmacy insights

40 extracted metrics across FY09–FY27.

Shareholding Pattern

As of Sep 2026

  • Public 65.88%
  • Promoters 29.98%
  • Others 4.14%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Prism Medico & Pharmacy

What does Prism Medico & Pharmacy Ltd do?
Incorporated in 1985, Prism Medico & Pharmacy Ltd manufactures, trades, and distributes chemicals, medicines, pharmaceuticals, cosmetics, and related products
Where is Prism Medico & Pharmacy Ltd (PRISMMEDI) listed?
Prism Medico & Pharmacy Ltd trades under code 512217 on the BSE.
Which sector does Prism Medico & Pharmacy Ltd belong to?
Prism Medico & Pharmacy Ltd is classified under the Financial Services sector, in the NBFC industry.
What is the 52-week high and low of Prism Medico & Pharmacy Ltd?
Over the last 52 weeks Prism Medico & Pharmacy Ltd has traded between ₹15.51 and ₹37 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Prism Medico & Pharmacy Ltd?
Prism Medico & Pharmacy Ltd reported a return on equity of 2.10%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1985, Prism Medico & Pharmacy Ltd manufactures, trades, and distributes chemicals, medicines, pharmaceuticals, cosmetics, and related products

Website prismmedicos.com
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/512217.md for Prism Medico & Pharmacy Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More NBFC & Finance stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month